Intellectual Property Litigation - - BioPharm International

ADVERTISEMENT

Intellectual Property Litigation


BioPharm International
Volume 1, Issue 8

13. Bibby K, Davis J, Jones, J. Biopharmaceuticals—moving to centre stage. BioPeople. 2003:10 (available at http:// http://www.imshealth.com/vgn/images/portal/cit_40000873/43028586Bio_Moving_to_Centre_Stage.pdf ).

14. Benassi J, Wolff J. The rise of generic and "branded generics" cause dramatic increase in pharmaceutical patent litigation. IP Today. January 2004:8.

15. American Intellectual Property Law Association (AIPLA). Report of the Economic Survey. Arlington, Va: AIPLA; 2003:Table 22.

Gary N. Frischling, J.D., is a partner at Irell & Manella LLP, 1800 Avenue of the Stars, Suite 900, Los Angeles, CA 90067, 310.277.1010, fax 310.203.7199,

Keith A. Orso, J.D., is an associate at Irell & Manella LLP, 1800 Avenue of the Stars, Suite 900, Los Angeles, CA 90067, 310.277.1010, fax 310.203.7199,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

GPhA Issues Statement on Generic Drug Costs
November 20, 2014
Amgen Opens Single-Use Manufacturing Plant in Singapore
November 20, 2014
Manufacturing Issues Crucial to Combating Ebola
November 20, 2014
FDA Requests Comments on Generic Drug Submission Criteria
November 20, 2014
USP Joins Chinese Pharmacopoeia Commission for Annual Science Meeting
November 20, 2014
Author Guidelines
Source: BioPharm International,
Click here